Skip to main content
. 2020 May 26;9(6):282. doi: 10.3390/antibiotics9060282

Table 1.

Demographics and Baseline Data.

Pre-Intervention
(n = 81)
Post-Intervention
(n = 79)
p Value
Age, years, mean ± SD 50.6 ± 20.1 49.9 ± 17.5 0.8
Female sex, n (%) 35 (43.2) 49 (62) 0.02
Race 0.10
  White, n (%) 60 (74.1) 63 (79.7)
  African American, n (%) 18 (22.2) 9 (11.4)
  Other/unknown, n (%) 3 (3.7) 7 (8.9)
ICU admission, n (%) 26 (32.1) 19 (24.1) 0.26
30-day mortality, n (%) 5 (6.2) 3 (3.8) 0.72
Peripheral WBC, k/µL, mean ± SD 9.6 ± 4.2 10.5 ± 6.1 0.29
CSF WBC, per µL, mean ± SD 61 ± 157 162 ± 798 0.27
CSF neutrophils, %, mean ± SD 21 ± 31 18 ± 29 0.51
CSF lymphocytes, %, mean ± SD 58 ± 33 58 ± 34 0.94
CSF glucose, mg/dL, mean ± SD 80 ± 38 76 ± 26 0.37
CSF protein, mg/dL, mean ± SD 57 ± 34 60 ± 46 0.56
Traumatic LP, n (%) 8 (9.9) 6 (7.6) 0.61
Antimicrobial pretreatment prior to LP, n (%) 36 (44.4) 33 (41.8) 0.73

Abbreviations: SD: Standard deviation, ICU: Intensive care unit, WBC: White blood cell count, CSF: Cerebrospinal fluid, LP: Lumbar puncture.